Having trouble viewing this email? View in your browser.

20 June 2017

Dear colleagues,

As you may know, the European Medicines Agency (EMA) launched the clinical data website on 20 October 2016 in line with its policy on the publication of clinical data (Policy 0070). EMA is dedicating a significant amount of time and effort to this activity. Whilst extensive stakeholder consultation on the policy took place during its development, it is important to get more information on the experience gained during the first few months following the launch of the website. Concrete information on who is accessing the clinical data, why users access the data, and how useful the data have been could help to further develop EMA’s transparency policies. In addition, it will be useful to gather feedback on the usability of the new website.

The ESCMID Position Paper “Use of Nebulized Antimicrobials for the Treatment of Respiratory Infections in Invasively Mechanically Ventilated Adults” is now freely available in CMI.

ESCMID Executive Office
Gerbergasse 14
4001 Basel
Phone +41 61 508 0150
Visit us on mastodon Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.